Cargando…
Axillary Needle Biopsy in the Era of American College of Surgeons Oncology Group (ACOSOG) Z0011: Institutional Experience With a Largely Urban Minority Population and Review of the Literature
Background: The American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated that sentinel lymph node biopsy (SLNB) alone is adequate for axillary control in patients with one to two positive axillary lymph nodes. However, axillary lymph node dissection (ALND) is required in patient...
Autores principales: | Choi, Lydia, Ku, Kimberly, Chen, Wei, Shahait, Awni D, Kim, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122337/ https://www.ncbi.nlm.nih.gov/pubmed/35607532 http://dx.doi.org/10.7759/cureus.24317 |
Ejemplares similares
-
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
por: Gebhardt, Brian J., et al.
Publicado: (2018) -
Axillary Treatment Management in Breast Cancer during COVID-19 Pandemic (Association between ACOSOG Z0011 Criteria and OSNA Test)
por: Anedda, Giacomo, et al.
Publicado: (2023) -
The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study
por: Liu, Miao, et al.
Publicado: (2015) -
Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study
por: Peng, Yuan, et al.
Publicado: (2021) -
Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?
por: Liu, Miao, et al.
Publicado: (2019)